Galapagos Acquires CellPoint and AboundBio for Next-Generation Cell Therapies
By Swati Sharan
Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)
Published: 5 Jul-2022
DOI: 10.3833/pdr.v2022.i7.2701 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In an attempt to expedite access to next-generation cell therapies, Galapagos has agreed to acquire CellPoint in an all-cash transaction of up to €225 M (US$237...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS